From messengers to receptors in psoriasis: the role of IL-17RA in disease and treatment

S Vidal, L Puig, JM Carrascosa-Carrillo… - International journal of …, 2021 - mdpi.com
The paradigm of psoriasis as a Th17-driven disease has evolved in the last years towards a
much deeper knowledge of the complex pathways, mechanisms, cells, and messengers …

A practical guide to the management of oral candidiasis in patients with plaque psoriasis receiving treatments that target interleukin-17

AW Armstrong, A Blauvelt, U Mrowietz, B Strober… - Dermatology and …, 2022 - Springer
Plaque psoriasis is an immune-mediated inflammatory skin disease associated with the
dysregulation of cytokines, especially those involved in the interleukin (IL)-23/IL-17 …

[HTML][HTML] Mouse model of a human STAT4 point mutation that predisposes to disseminated coccidiomycosis

DA Powell, AP Hsu, LF Shubitz, CD Butkiewicz… - …, 2022 - journals.aai.org
STAT4 plays a critical role in the generation of both innate and adaptive immune responses.
In the absence of STAT4, Th1 responses, critical for resistance to fungal disease, do not …

Interleukin inhibitors and the associated risk of candidiasis

S Khan, H Bilal, MN Khan, W Fang, W Chang… - Frontiers in …, 2024 - frontiersin.org
Interleukins (ILs) are vital in regulating the immune system, enabling to combat fungal
diseases like candidiasis effectively. Their inhibition may cause enhanced susceptibility to …

Risk of infections in psoriasis: assessment and challenges in daily management

C De Simone, MC Fargnoli, P Amerio… - Expert Review of …, 2021 - Taylor & Francis
Introduction In daily practice management of psoriasis, evaluation of risk factors for
infections is having a growing influence. Indeed, in psoriatic patients, risk of infections may …

Infections in the era of immunobiologicals

R Romiti, ALS Hirayama, AM Porro… - Anais Brasileiros de …, 2024 - SciELO Brasil
Immunobiologicals represent an innovative therapeutic option in dermatology. They are
indicated in severe and refractory cases of different diseases when there is contraindication …

[HTML][HTML] Management Of Infections In Psoriatic Patients Treated With Systemic Therapies: A Lesson From The Immunopathogenesis Of Psoriasis

A Balato, E Scala, K Eyerich, NC Brembilla… - Dermatology Practical …, 2023 - ncbi.nlm.nih.gov
Modern treatments continue to be developed based on identifying targets within the innate
and adaptive immune pathways associated with psoriasis. Whilst there is a sound biologic …

Low incidence of invasive fungal infections in a large observational cohort of patients initiating IL-17 or IL-23 inhibitor therapy, United States, 2016-2022

NC Bahr, K Benedict, M Toda, JAW Gold… - Journal of the American …, 2024 - Elsevier
Low Incidence of Invasive Fungal Infections in a Large Observational Cohort of Patients Initiating
IL-17 or IL-23 Inhibitor Ther Page 1 Journal Pre-proof Low Incidence of Invasive Fungal Infections …

双氢青蒿素通过调节Th17/Treg 平衡改善银屑病小鼠皮损机制研究

江从军, 周艳梅 - 蚌埠医学院学报, 2022 - xuebao.bbmu.edu.cn
双氢青蒿素通过调节Th17/Treg平衡改善银屑病小鼠皮损机制研究江从军,周艳梅引用本文: 江
从军, Page 1 双氢青蒿素通过调节Th17/Treg平衡改善银屑病小鼠皮损机制研究 江从军,周艳梅 …

Biologics and small molecule inhibitors for hidradenitis suppurativa

T Shih, DR De, VY Shi, JL Hsiao - Dermatological Reviews, 2022 - Wiley Online Library
Background Hidradenitis suppurativa (HS) is a debilitating, chronic inflammatory dermatosis
that is often recalcitrant to first‐line treatments. Though mechanisms underlying its pathology …